Results 131 to 140 of about 21,470 (167)

Next-generation macrophage engineering in cancer therapy: From TAM reprogramming to CAR-macrophages. [PDF]

Mol Ther Nucleic Acids
Nilova O, Zajakina A.
europepmc   +1 more source

Dual Graphene Oxide-Based Multigene Delivery for Cancer Elimination via Stromal and Immune Reprogramming. [PDF]

Int J Biomater
Grilli F, Sakib S, Variola F, Zou S.
europepmc   +1 more source

Guiding pluripotent stem cell therapies past the immune system. [PDF]

Stem Cells Transl Med
Pizzato HA, Bhattacharya D.
europepmc   +1 more source

The CD47 signaling axis regulates the formation and vulnerability of atherosclerotic plaques: mechanism analysis and targeting strategies. [PDF]

Front Immunol
Bai L, Xu B, Chen Y, Fu D, Wang L, Ma D.
europepmc   +1 more source

TBL1XR1 mutations promoted tumor progression in diffuse large B-cell lymphoma through impairing nature killer cytotoxicity via the MYC-CD47/PD-L1 axis. [PDF]

Mol Cancer
Zhu Y, Shen YG, Tang W, Zheng Z, Chen SY, Huang YH, Fu D, Cheng S, Xu PP, Wang L, Chen J, Ji MM, Zhao WL.   +12 more
europepmc   +1 more source

High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma. [PDF]

Nat Commun
Pagès-Geli C, Ribeiro J, Wienclaw T, Meglan AM, Sloat L, Silva M, Blandin J, Velarde J, Vaccaro K, Sebastiany C, Fernández-Guzmán P, Hahn CK, Crespo M, Weiskopf K.   +13 more
europepmc   +1 more source

Axitinib promotes stemness and vasculogenic mimicry in triple-negative breast cancer by disrupting THBS1-CD47 axis-mediated endothelial-tumor cell communication. [PDF]

Apoptosis
Lei L, Zhou H, Lai X, Wang Z, Li R, Du C, He X, Du L, Zheng Y, Wang X, Shao X.   +10 more
europepmc   +1 more source

Spatial and Temporal Heterogeneity of Macrophage Efferocytosis in Tumors: Emerging Implications for Immunotherapy Biomarkers and Therapeutic Timing. [PDF]

Cancer Med
Li S, Li J, Zhang Z, Wang S, Ma C.
europepmc   +1 more source

Immunomodulatory role and therapeutic potential of thrombospondin-1 during infectious diseases and autoimmunity. [PDF]

BMC Biol
Román F, Jara A, Jara-Collao A, Novoa F, Moreno-Quidecoy C, Chavez V, Urzúa F, Moreno D, Bueno SM, González PA, Kalergis AM, Peñaloza HF.   +11 more
europepmc   +1 more source

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]

Blood Neoplasia
Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.   +29 more
europepmc   +1 more source